Abstract
Cytochrome P450 enzymes are a large family of heme-containing proteins that have important functions in the biotransformation of xenobiotics, including pharmacologic and environmental agents, as well as endogenously produced chemicals with broad structural and functional diversity. Anandamide and 2-arachidonoylglycerol (2-AG) are substrates for P450s expressed in multiple tissues, leading to the production of a diverse set of mono- and di-oxygenated metabolites. This chapter describes tools and methods that have been used to identify major endocannabinoid metabolizing P450s and their corresponding products using subcellular tissue fractions, cultured cells, and purified recombinant enzymes in a reconstituted system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Snider NT, Walker VJ, Hollenberg PF (2010) Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. Pharmacol Rev 62(1):136–154
Zelasko S, Arnold WR, Das A (2015) Endocannabinoid metabolism by cytochrome P450 monooxygenases. Prostaglandins Other Lipid Mediat 116-117:112–123
Rouzer CA, Marnett LJ (2011) Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways. Chem Rev 111(10):5899–5921
Sridar C, Snider NT, Hollenberg PF (2011) Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6. Drug Metab Dispos 39(5):782–788
Snider NT, Sikora MJ, Sridar C, Feuerstein TJ, Rae JM, Hollenberg PF (2008) The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. J Pharmacol Exp Ther 327(2):538–545
Snider NT, Kornilov AM, Kent UM, Hollenberg PF (2007) Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. J Pharmacol Exp Ther 321(2):590–597
McDougle DR, Kambalyal A, Meling DD, Das A (2014) Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase. J Pharmacol Exp Ther 351(3):616–627
Stark K, Dostalek M, Guengerich FP (2008) Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. FEBS J 275(14):3706–3717
Bornheim LM, Kim KY, Chen B, Correia MA (1995) Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. Biochem Pharmacol 50(5):677–686
Walker VJ, Griffin AP, Hammar DK, Hollenberg PF (2016) Metabolism of anandamide by human cytochrome P450 2J2 in the reconstituted system and human intestinal microsomes. J Pharmacol Exp Ther 357(3):537–544
Rand AA, Helmer PO, Inceoglu B, Hammock BD, Morisseau C (2018) LC-MS/MS analysis of the epoxides and diols derived from the endocannabinoid arachidonoyl ethanolamide. Methods Mol Biol (Clifton, NJ) 1730:123
Snider NT, Nast JA, Tesmer LA, Hollenberg PF (2009) A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist. Mol Pharmacol 75(4):965–972
Chen JK, Chen J, Imig JD, Wei S, Hachey DL, Guthi JS et al (2008) Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors. J Biol Chem 283(36):24514–24524
Chen J, Chen JK, Falck JR, Guthi JS, Anjaiah S, Capdevila JH et al (2007) Mitogenic activity and signaling mechanism of 2-(14,15- epoxyeicosatrienoyl)glycerol, a novel cytochrome p450 arachidonate metabolite. Mol Cell Biol 27(8):3023–3034
Dempsey SK, Gesseck AM, Ahmad A, Daneva Z, Ritter JK, Poklis JL (2019) Formation of HETE-EAs and dihydroxy derivatives in mouse kidney tissue and analysis by high-performance liquid chromatography tandem mass spectrometry. J Chromatogr B 1126:121748
Watson JE, Kim JS, Das A (2019) Emerging class of omega-3 fatty acid endocannabinoids & their derivatives. Prostaglandins Other Lipid Mediat 143:106337
McDougle DR, Watson JE, Abdeen AA, Adili R, Caputo MP, Krapf JE et al (2017) Anti-inflammatory ω-3 endocannabinoid epoxides. Proc Natl Acad Sci U.SA 114(30):E6034–E6043
Jia L, Liu X (2007) The conduct of drug metabolism studies considered good practice (II): in vitro experiments. Curr Drug Metab 8(8):822–829
Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, Mellottee L et al (2009) Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos 37(7):1528–1538
Guguen-Guillouzo C, Guillouzo A (2010) General review on in vitro hepatocyte models and their applications. Methods Mol Biol 640:1–40
Corbett JL, Duncan SA (2019) iPSC-derived hepatocytes as a platform for disease modeling and drug discovery. Front Med 6:265
Prior N, Inacio P, Huch M (2019) Liver organoids: from basic research to therapeutic applications. Gut 68(12):2228–2237
Pearce RE, McIntyre CJ, Madan A, Sanzgiri U, Draper AJ, Bullock PL et al (1996) Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Arch Biochem Biophys 331(2):145–169
Acknowledgments
This work was supported in part by the National Institutes of Health Grants CA16954, GM007767 and DK110355.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Snider, N.T., Hollenberg, P.F. (2023). Assay of Endocannabinoid Oxidation by Cytochrome P450. In: Maccarrone, M. (eds) Endocannabinoid Signaling. Methods in Molecular Biology, vol 2576. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2728-0_27
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2728-0_27
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2727-3
Online ISBN: 978-1-0716-2728-0
eBook Packages: Springer Protocols